Mannitol-Infusionslösung 10

Mannitol, the active ingredient in Mannitol-Infusionslösung 10, is a osmotic diuretic presented as an injection solution for intravenous use. It increases osmotic pressure in renal tubules and extracellular fluid, promoting diuresis and reducing intracranial pressure.

GNH USA supplies Mannitol-Infusionslösung 10 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannitol is employed in clinical situations where osmotic diuresis or reduction of fluid pressure is required.

- Cerebral edema: lowers intracranial pressure and helps control brain swelling. - Acute renal failure (oliguria): enhances urine output to support renal clearance. - Acute glaucoma: rapidly decreases intra‑ocular pressure during an attack.

Mannitol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea: feeling of unease or urge to vomit. - Vomiting: expulsion of stomach contents. - Thirst: increased desire for fluids. - Dizziness: sensation of light‑headedness. - Electrolyte imbalance: changes in sodium or potassium levels.

Serious or Rare Side Effects: - Acute renal failure: sudden loss of kidney function. - Pulmonary edema: fluid accumulation in the lungs. - Severe hyponatremia: dangerously low blood sodium. - Anaphylactic reaction: severe allergic response. - Hemolysis: destruction of red blood cells. - Metabolic acidosis: excess acidity in the body.

Mannitol administration requires careful monitoring and adherence to safety guidelines.

- Renal function: assess baseline kidney status and monitor creatinine. - Electrolyte balance: check serum sodium and potassium regularly. - Fluid status: avoid overload; monitor input and output. - Pregnancy: use only if potential benefit justifies potential risk. - Contraindications: do not administer to patients with severe renal impairment or anuria. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with other medications, affecting safety and efficacy.

Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte disturbances. - Nephrotoxic agents (e.g., aminoglycosides): increase risk of renal injury. - Insulin: enhanced hypoglycaemic effect due to altered fluid shifts.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt diuretic response. - Antihypertensives: additive blood pressure lowering. - Corticosteroids: potential for increased fluid retention.